Cargando…

A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro

BACKGROUND: Elevated glucose concentrations lead to increased insulin secretion and suppression of glucagon secretion. In fact, insulin is a physiological inhibitor of glucagon secretion. Type 2 diabetes mellitus (T2DM) patients have defects in insulin secretion. In addition to this, lack of suppres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verma, Mahesh Kumar, Biswas, Sanghamitra, Chandravanshi, Bhawna, Neelima, Korrapati, Oommen, Anup M, Jagannath, Madanahalli R, Somesh, Baggavalli P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161845/ https://www.ncbi.nlm.nih.gov/pubmed/25186493 http://dx.doi.org/10.1186/1756-0500-7-595

Ejemplares similares

CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients
por: Sunil, Venkategowda, et al.
Publicado: (2014)

Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats
por: Gowda, Nagesh, et al.
Publicado: (2013)

Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activity
por: Somesh, Baggavalli P, et al.
Publicado: (2013)

Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function
por: Verma, Mahesh Kumar, et al.
Publicado: (2014)

Integrated analysis of chronic lipotoxicity on muscle metabolism and stress and its reversal by antioxidants
por: Verma, Mahesh Kumar, et al.
Publicado: (2014)

Inhibition of neutral sphingomyelinases in skeletal muscle attenuates fatty-acid induced defects in metabolism and stress
por: Verma, Mahesh Kumar, et al.
Publicado: (2014)

CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models
por: Anil, Tharappel M, et al.
Publicado: (2014)

CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models
por: Sadasivuni, Manoj Kumar, et al.
Publicado: (2014)

A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits
por: Anil, Tharappel M, et al.
Publicado: (2014)

Human Pancreatic Islets React to Glucolipotoxicity by Secreting Pyruvate and Citrate
por: Perrier, Johan, et al.
Publicado: (2023)

FGF-23 protects cell function and viability in murine pancreatic islets challenged by glucolipotoxicity
por: Pajaziti, Betina, et al.
Publicado: (2022)

Insights into the Cnx1E catalyzed MPT-AMP hydrolysis
por: Hercher, Thomas W., et al.
Publicado: (2020)

Par-4/NF-κB Mediates the Apoptosis of Islet β Cells Induced by Glucolipotoxicity
por: QiNan, Wu, et al.
Publicado: (2016)

GPR142 prompts glucagon-like Peptide-1 release from islets to improve β cell function
por: Lin, Hua V., et al.
Publicado: (2018)

Glucolipotoxicity in Pancreatic β-Cells
por: Kim, Ji-Won, et al.
Publicado: (2011)

Cardiac Glucolipotoxicity and Cardiovascular Outcomes
por: Cerf, Marlon E.
Publicado: (2018)

Glucolipotoxicity and GLP-1 secretion
por: Hong, Jung-Hee, et al.
Publicado: (2021)

Electrospun Mats Based on PVA/NaDDBS/CNx Nanocomposite for Electrochemical Sensing
por: Vilchis-León, Paloma, et al.
Publicado: (2021)

Cyclopropane-Containing Fatty Acids from the Marine Bacterium Labrenzia sp. 011 with Antimicrobial and GPR84 Activity
por: Amiri Moghaddam, Jamshid, et al.
Publicado: (2018)

Fast food diet with CCl4 micro-dose induced hepatic-fibrosis –a novel animal model
por: Chheda, Tarak K, et al.
Publicado: (2014)

Gut Metabolite Trimethylamine N-Oxide Protects INS-1 β-Cell and Rat Islet Function under Diabetic Glucolipotoxic Conditions
por: Krueger, Emily S., et al.
Publicado: (2021)

Developing an in vitro screening assay platform for evaluation of antifibrotic drugs using precision-cut liver slices
por: Sadasivan, Satish Kumar, et al.
Publicado: (2014)

Microcosm 2.011
por: CERN Bulletin
Publicado: (2011)

Erratum. Glucolipotoxicity-Inhibited miR-299-5p Regulates Pancreatic β-Cell Function and Survival. Diabetes 2018;67:2280–2292
por: Huang, Qiqing, et al.
Publicado: (2019)

A forward genetic screen identifies chaperone CNX-1 as a conserved biogenesis regulator of ERG K(+) channels
por: Bai, Xue, et al.
Publicado: (2018)

Developmental Programming and Glucolipotoxicity: Insights on Beta Cell Inflammation and Diabetes
por: Cerf, Marlon E.
Publicado: (2020)

Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis
por: Yang, Yiqi, et al.
Publicado: (2022)

Intra-islet glucagon secretion and action in the regulation of glucose homeostasis
por: Wang, Qinghua, et al.
Publicado: (2013)

Melatonin and Pancreatic Islets: Interrelationships between Melatonin, Insulin and Glucagon
por: Peschke, Elmar, et al.
Publicado: (2013)

In vivo studies of glucagon secretion by human islets transplanted in mice
por: Tellez, Krissie, et al.
Publicado: (2020)

Small molecule glucagon release inhibitors with activity in human islets
por: Kalwat, Michael A., et al.
Publicado: (2023)

The Higher Plasma Malondialdehyde Concentrations Are Determined by Metabolic Syndrome-Related Glucolipotoxicity
por: Moreto, Fernando, et al.
Publicado: (2014)

JNK1 Protects against Glucolipotoxicity-Mediated Beta-Cell Apoptosis
por: Prause, Michala, et al.
Publicado: (2014)

Mesenchymal Stem Cells Ameliorated Glucolipotoxicity in HUVECs through TSG-6
por: An, Xingxing, et al.
Publicado: (2016)

Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretion
por: Ward, Meliza G., et al.
Publicado: (2017)

Activation of Aldehyde Dehydrogenase 2 Ameliorates Glucolipotoxicity of Pancreatic Beta Cells
por: Chen, Shiau-Mei, et al.
Publicado: (2021)

Phenotypic Screening for Small Molecules that Protect β-Cells from Glucolipotoxicity
por: Small, Jonnell C., et al.
Publicado: (2022)

Overexpression of a GmCnx1 Gene Enhanced Activity of Nitrate Reductase and Aldehyde Oxidase, and Boosted Mosaic Virus Resistance in Soybean
por: Zhou, Zheng, et al.
Publicado: (2015)

P011 Antifungal lock therapy
por: Koparkar, Vidyullata, et al.
Publicado: (2022)

Carnosine scavenging of glucolipotoxic free radicals enhances insulin secretion and glucose uptake
por: Cripps, Michael J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q5f8qieh6ospcsb2jbb1iid1vt